Evidence map›Paper›PMID 24239293›Full record

ArticleMolecular cell2013

Rrp5 binding at multiple sites coordinates pre-rRNA processing and assembly.

Simon Lebaron, Asa Segerstolpe, Sarah L French, Tatiana Dudnakova, Flavia de Lima Alves, Sander Granneman, Juri Rappsilber, Ann L Beyer, Lars Wieslander, David Tollervey

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. The homeostatic regulation of ribosome biogenesis.Seminars in cell & developmental biology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Simon LebaronWellcome Trust Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Kings Buildings, Mayfield Road, Edinburgh EH9 3JR, Scotland.
Asa SegerstolpeDepartment of Molecular Biosciences, WGI, Stockholm University, 106 91 Stockholm, Sweden.
Sarah L FrenchDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, VA 22908-0734, USA.
Tatiana DudnakovaWellcome Trust Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Kings Buildings, Mayfield Road, Edinburgh EH9 3JR, Scotland.
Flavia de Lima AlvesWellcome Trust Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Kings Buildings, Mayfield Road, Edinburgh EH9 3JR, Scotland.
Sander GrannemanSynthSys, JR Waddington Building, Kings Buildings, Mayfield Road, Edinburgh EH9 3JR, Scotland.
Juri RappsilberWellcome Trust Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Kings Buildings, Mayfield Road, Edinburgh EH9 3JR, Scotland.
Ann L BeyerDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, VA 22908-0734, USA.
Lars WieslanderDepartment of Molecular Biosciences, WGI, Stockholm University, 106 91 Stockholm, Sweden.
David TollerveyWellcome Trust Centre for Cell Biology, University of Edinburgh, Michael Swann Building, Kings Buildings, Mayfield Road, Edinburgh EH9 3JR, Scotland. Electronic address: d.tollervey@ed.ac.uk.
University of Edinburgh · GBStockholm University · SEUniversity of Virginia Health System · USWellcome Centre for Cell Biology · GB

Funding

Visualizing Genetic Activity in Normal & Mutant YeastR01GM063952 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BEYER, ANN L. · 2001 to 2013
$3.7M
NIGMS NIH HHS GM63952NIGMS NIH HHS R01 GM063952Wellcome Trust 077248Wellcome Trust 084229Wellcome Trust 091020Wellcome Trust 092076
6 · The paper itself

Abstract

In vivo UV crosslinking identified numerous preribosomal RNA (pre-rRNA) binding sites for the large, highly conserved ribosome synthesis factor Rrp5. Intramolecular complementation has shown that the C-terminal domain (CTD) of Rrp5 is required for pre-rRNA cleavage at sites A0-A2 on the pathway of 18S rRNA synthesis, whereas the N-terminal domain (NTD) is required for A3 cleavage on the pathway of 5.8S/25S rRNA synthesis. The CTD was crosslinked to sequences flanking A2 and to the snoRNAs U3, U14, snR30, and snR10, which are required for cleavage at A0-A2. The NTD was crosslinked to sequences flanking A3 and to the RNA component of ribonuclease MRP, which cleaves site A3. Rrp5 could also be directly crosslinked to several large structural proteins and nucleoside triphosphatases. A key role in coordinating preribosomal assembly and processing was confirmed by chromatin spreads. Following depletion of Rrp5, cotranscriptional cleavage was lost and preribosome compaction greatly reduced.

Indexed as

RNA Processing, Post-TranscriptionalBase SequenceBinding SitesEndoribonucleasesFungal ProteinsMolecular Sequence DataNucleoside-TriphosphataseRibosomesRNA, FungalRNA PrecursorsRNA, RibosomalYeastsEndoribonucleasesFungal Proteinsmitochondrial RNA-processing endoribonucleaseNucleoside-TriphosphataseRNA, FungalRNA PrecursorsRNA, Ribosomal

Identifiers

PMID24239293
PMCPMC3991325
OpenAlexW2140003283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.